Is Addus HomeCare Corporation (ADUS) Overvalued?
We dive into why Addus HomeCare Corporation (ADUS) could be considered overvalued on 2026-08-06, based on AAII’s Value Score and Grade.Rosalio Madrigal
Stock Evaluator: Addus HomeCare Corporation (ADUS)
Addus HomeCare Corporation ADUS
$118.06
1.17
1.00%
August 12, 2026 4:00:00 PM
EST
Volume: 185,535
After Hours: $120.37
0.15
|
0.12%
November 10, 2021 7:59 PM
EST
Volume: 72,713
USD
NASD | DELAYED PRICE
| SECTOR | INDUSTRY |
| Health Care | Health Care Providers & Services |
A+ Stock Grade Summary:
| VALUE: |
|
|
| GROWTH: |
|
|
| MOMENTUM: |
|
|
| EPS REVISIONS: |
|
|
| QUALITY: |
|
|
COMPANY SUMMARY
Addus HomeCare Corporation, together with its subsidiaries, provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States. The company operates through three segments: Personal Care, Hospice, and Home Health. Its Personal Care segment provides non-medical assistance with activities of daily living. This segment offers services that include assistance with bathing, grooming, oral care, feeding and dressing, medication reminders, meal planning and preparation, housekeeping, and transportation services. The Hospice segment provides palliative nursing care, social work, spiritual counseling, homemaker, and bereavement counseling services for people who are terminally ill, as well as related services for their families. Its Home Health segment offers skilled nursing and physical, occupational, and speech therapy for the individuals who requires assistance during an illness or after hospitalization. The company serves federal, state, and local governmental agencies; managed care organizations; commercial insurers; and private individuals. Addus HomeCare Corporation was founded in 1979 and is based in Frisco, Texas.
Commentary & Analysis
What You Need to Know About Addus HomeCare Corporation's Q3 Earnings
Addus HomeCare Corporation's fiscal Q3 earnings report was released on Monday, August 03. Let's dive in to see if (ADUS) missed or beat analyst's expectations.Michael Rose
Which Is a Better Investment, Addus HomeCare Corporation or NeoGenomics, Inc. Stock?
Learn more about whether Addus HomeCare Corporation or NeoGenomics, Inc. is a better investment based on AAII's A+ Investor grades, which compare both companies' key financial metrics.Jenna Brashear
Which Is a Better Investment, Addus HomeCare Corporation or agilon health, inc. Stock?
Learn more about whether Addus HomeCare Corporation or agilon health, inc. is a better investment based on AAII's A+ Investor grades, which compare both companies' key financial metrics.Jenna Brashear
Which Is a Better Investment, Addus HomeCare Corporation or Universal Health Services, Inc. Stock?
Learn more about whether Addus HomeCare Corporation or Universal Health Services, Inc. is a better investment based on AAII's A+ Investor grades, which compare both companies' key financial metrics.Michael Rose
Financial Summary
| Share Statistics | ADUS | Industry Median |
Percentile (All Stocks) |
|
| Market Cap (Mil) | $2,189.3 | $1,947.0 | 55% |
|
| Shares Out (Mil) | 18.5 | 81.7 | 29% |
|
| Institutional Ownership | 97.3% | 87.9% | 73% |
|
| Float (Mil) | 17.4 | 51.6 | 27% |
|
| Beta | 0.86 | 0.84 | 51% |
|
| Avg Daily Volume (000s) | 238 | 618 | 47% |
|
| Price Change (52-week) |
4.1% | 80.4% | 46% |
|
| Growth | ADUS | Industry Median |
Percentile (All Stocks) |
|
| Sales (5yr) | 13.2% | 10.8% | 68% |
|
| Net Income (5yr) | 23.7% | (0.3%) | 78% |
|
| EPS (5yr) | 20.2% | 3.1% | 68 |
|
| Dividends (5yr) | 0.0% | 0.0% | 0% |
|
| Cash Flow (5yr) | (19.6%) | (18.0%) | 34% |
|
| Estimates | Qtrly | Current Fiscal Year |
Next Fiscal Year |
|
| # of Estimates | 13 | 13 | 14 | |
| Current EPS | $1.791 | $7.050 | $7.504 | |
| Month Ago EPS | $1.762 | $6.988 | $7.473 | |
| # Rev Up | 3 | 2 | 2 | |
| # Rev Down | 0 | 0 | 0 | |
| Three Months Ago EPS | $1.765 | $6.998 | $7.475 | |
| Year/Year Chg | 20.2% | 35.1% | 51.7% | |
| Financials | ADUS | Industry Median |
Percentile (All Stocks) |
|
| Sales (TTM) (Mil) | $1,476 | $1,476 | 56% |
|
| Net Income (TTM) (Mil) | $105 | $17 | 61% |
|
| EPS (TTM) | $5.796 | $0.200 | 88% |
|
| Operating Cash Flow (TTM) (Mil) | $162 | $139 | 57% |
|
| Net Cash Flow (TTM) (Mil) | $8 | $8 | 56% |
|
| Long-Term Debt (Q1) (Mil) | $96 | $328 | 44% |
|
| Enterprise Value (Q1) (Mil) | $2,140 | $2,140 | 51% |
|
| Valuation | ADUS | Industry Median |
Percentile (All Stocks) |
|
| P/B | 1.91 | 2.84 | 48% |
|
| P/E | 21.0 | 25.5 | 52% |
|
| Dividend Yield | 0.0% | 0.0% | 0% |
|
| PEG (5yr hist) | 1.0 | 1.0 | 46% |
|
| Ratios | ADUS | Industry Median |
Percentile (All Stocks) |
|
| Gross Margin | 32.4% | 27.9% | 39% |
|
| Net Margin | 7.1% | 1.3% | 55% |
|
| ROA | 7.4% | 1.9% | 81% |
|
| ROE | 9.7% | 7.6% | 57% |
|
| Liabilities to Assets | 21.2% | 60.8% | 13% |
|
| F-Score | 6 | 5 | 68% |
|
Passing Stock Screens
As of 8/7/2026, from a list of 60 stock screening strategies,
FACTOR STRATEGY
P/E Relative Screen
Factors: Value, Earnings Estimates
A screen that looks at the relationship of a stock's price-earnings ratio to that of the industry and market.
| Performance Since Inception: | 13.7% |
| +/- S&P 500: | +6.2 |
